Abstract
Serum des-γ-carboxy prothrombin (DCP) is commonly used to detect hepatocellular carcinoma (HCC). This review focuses on the clinical features of DCP-positive HCC and the molecular function of DCP in HCC. DCP-positive HCC demonstrates more aggressive clinicopathological features than DCP-negative HCC. Analysis of the biological effects of DCP revealed that DCP acts as a growth factor in both an autocrine and paracrine manner. DCP stimulates HCC cell proliferation through the Met-Janus kinase 1-signal transducer and activator of transcription 3 signaling pathway, whereas for vascular endothelial cells, it stimulates cell proliferation and migration through the kinase insert domain receptor-phospholipase C-γ-mitogen-activated protein kinase signaling pathway.
Original language | English |
---|---|
Pages (from-to) | 299-304 |
Number of pages | 6 |
Journal | Acta medica Okayama |
Volume | 63 |
Issue number | 6 |
Publication status | Published - Dec 2009 |
Keywords
- Angiogenesis
- Cell proliferation
- Des-γ-carboxy prothrombin
- Hepatocellular carcinoma
- Signaling pathway
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)